Lastly, inhibition of the UPRmt worsens cellular features commonly associated with AD such as an increased Aβ42:Aβ40 ratio and increased phosphorylated tau in an AD-like human cerebral organoid model (Pérez et al., 2020). The gene discussed is MAPT; the disease is Alzheimer disease.